Tevogen Bio Holdings (TVGN) said late Friday that it broadened its relationship with Microsoft (MSFT) to expand its artificial intelligence-focused collaboration while building a technology designed to help with predictive precision T-cell targeting.
Shares of Tevogen advanced 30% as intraday trading volume soared to more than 48.5 million from a daily average of about 2.9 million.
Aurora Mobile (JG) said Monday that its business-oriented AI agent platform GPTBots.ai integrated the DeepSeek R1 large language model.
Shares skyrocketed 166% as intraday trading volume surged to over 28.5 million from a daily average of about 15,000.
Akero Therapeutics (AKRO) said Monday a phase 2b study of its lead product candidate, efruxifermin, showed a "statistically significant" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.
Shares surged more than 91% as intraday trading volume catapulted to over 11.7 million from a daily average of about 723,000.
Price: 1.75, Change: +0.40, Percent Change: +29.70
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。